First Trust Direct Indexing’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,836
Closed -$846K 960
2024
Q3
$846K Buy
7,836
+943
+14% +$103K 0.05% 403
2024
Q2
$748K Sell
6,893
-630
-8% -$74.3K 0.05% 388
2024
Q1
$993K Buy
7,523
+184
+3% +$23K 0.07% 299
2023
Q4
$893K Sell
7,339
-725
-9% -$80.9K 0.08% 292
2023
Q3
$905K Sell
8,064
-361
-4% -$45.8K 0.1% 224
2023
Q2
$1.23M Buy
8,425
+502
+6% +$68.2K 0.14% 168
2023
Q1
$1.02M Buy
7,923
+1,539
+24% +$193K 0.12% 201
2022
Q4
$814K Sell
6,384
-537
-8% -$62.3K 0.11% 253
2022
Q3
$724K Sell
6,921
-9
-0.1% -$988 0.11% 250
2022
Q2
$728K Buy
6,930
+1,759
+34% +$209K 0.1% 262
2022
Q1
$661K Buy
5,171
+335
+7% +$40.4K 0.08% 310
2021
Q4
$596K Buy
4,836
+183
+4% +$23.9K 0.08% 309
2021
Q3
$661K Buy
4,653
+583
+14% +$85.8K 0.09% 271
2021
Q2
$635K Buy
4,070
+898
+28% +$145K 0.09% 275
2021
Q1
$493K Buy
3,172
+246
+8% +$38.1K 0.13% 214
2020
Q4
$438K Buy
+2,926
New +$413K 0.12% 214

Other funds holding ZBH

First Trust Direct Indexing's ZBH Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 7,836 shares — an estimated $846K sold.

First Trust Direct Indexing first reported a position in ZBH in Q4 2020 and held it in 16 quarters. The position peaked at $1.23M in Q2 2023. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 7,836 Zimmer Biomet shares in Q4 2024, an estimated $846K.
  • First Trust Direct Indexing first reported a position in Zimmer Biomet in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Zimmer Biomet position peaked at $1.23M in Q2 2023.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.